Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future directions in myoma research.

Pavna K Brahma1, Kristina M Martel, Gregory M Christman

  • 1Department of Obstetrics and Gynecology, University of Michigan Health System, University of Michigan Medical School, 6422 Medical Science I, 1150 West Medical Center Drive, Ann Arbor, MI 48105, USA.

Obstetrics and Gynecology Clinics of North America
|March 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene.

Clinical and translational science·2025
Same author

Fertility in the Digital Age: A Survey-Based Evaluation of Fertility App Users' Quality of Life.

Reproductive sciences (Thousand Oaks, Calif.)·2024
Same author

Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids.

BMJ open·2024
Same author

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.

Nutrients·2023
Same author

Methods of Ovarian Tissue Cryopreservation: Is Vitrification Superior to Slow Freezing?-Ovarian Tissue Freezing Methods.

Reproductive sciences (Thousand Oaks, Calif.)·2021
Same author

Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes.

Fertility and sterility·2020
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

This review covers current knowledge and future research in uterine fibroids (leiomyomas). Advancements in genetic diagnosis and minimally invasive treatments promise to revolutionize patient care.

Area of Science:

  • Reproductive Medicine and Gynecology
  • Oncology
  • Genetics

Background:

  • Uterine fibroids (leiomyomas) are common benign tumors with significant impact on women's health.
  • Current understanding involves cytogenetics, signaling pathways, and second messenger molecules.
  • Existing medical and surgical treatments face challenges, including barriers to minimally invasive procedures.

Purpose of the Study:

  • To summarize current knowledge on uterine fibroids.
  • To outline future directions for fibroid research and treatment over the next decade.
  • To highlight emerging innovations that may revolutionize fibroid therapy.

Main Methods:

  • Review of available data on fibroid cytogenetics.
  • Discussion of discoveries in leiomyoma signaling pathways and second messenger molecules.

Related Experiment Videos

  • Summary of current medical management, surgical trends, and barriers to minimally invasive techniques.

    • Main Results:

    • Uterine fibroid research is advancing through understanding of molecular mechanisms.
    • Innovations in genetic diagnosis offer potential for personalized treatment approaches.
    • Interventional radiology-aided therapies show promise for specific patient groups.

    Conclusions:

    • Future fibroid research is focused on tissue-specific medical management and pharmacogenetics.
    • Minimally invasive surgical techniques are becoming more prevalent.
    • Emerging technologies in genetic diagnosis and interventional radiology herald a new era in fibroid treatment.